Sydney Neuroimaging Analysis Centre, an integrated neuroimaging research and commercial medical image analysis facility within the University of Sydney’s Brain and Mind Centre, has secured government ...
The field of Neuroimmunology, and particularly research surrounding Multiple Sclerosis (MS), has experienced rapid growth and unprecedented innovation over ...
Glenn Wylie, DPhil is director of the Rocco Ortenzio Neuroimaging Center and recipient of a National Multiple Sclerosis Society grant. East Hanover, NJ — April 9, 2024 —The National Multiple Sclerosis ...
In recent years, researchers studying multiple sclerosis have concluded that white matter lesion volume in the brain, long considered the best way to monitor MS disease progression, may not be the ...
BUFFALO, N.Y. – For people with multiple sclerosis (MS), hearing a doctor tell them they are experiencing brain atrophy—an important, predictive biomarker of MS disease progression—can trigger ...
Evaluating the central vein sign (CVS) with a 35% proportional threshold on 3 Tesla (3T) MRI offers high sensitivity and specificity in distinguishing multiple sclerosis (MS) from migraine, a new ...
In recent years, researchers studying multiple sclerosis have concluded that white matter lesion volume in the brain, long considered the best way to monitor MS disease progression, may not be the ...
East Hanover, NJ – June 3, 2024 – Nancy D. Chiaravalloti, PhD, has been awarded the 2024 Fred Foley Award for her contributions to significant advances in the understanding and treatment of memory ...
The faster patients can be diagnosed with multiple sclerosis, the sooner they can begin taking the powerful medications that can prevent further brain damage. Subscribe to our newsletter for the ...
Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to introduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results